New search | Conferencedetail
mail
Print view
 
 

4th Treg Directed Therapies Summit

Evvnt Promotion / evvnt
Archive
-
17.05.2022 - 19.05.2022  Embassy Suites by Hilton Boston at Logan Airport, 207 Porter Street, 02128 Boston, USA
Time: 09:00 - 17:30
 
Conference themes
As Biopharma turn their focus to autoimmune drug development, there has been an explosion of interest and investment into Treg directed therapies. Promising proof-of-concept data and early clinical read outs have fueled further hype, and the industry now looks to demonstrate efficacy.

The 4th Treg Directed Therapies Summit returns to Boston this May, bigger and better than ever before, boasting 2 tracks of unparalleled content to cater to cell-based, and non-cell-based experts alike.
Professional congress organizer (PCO)
Hanson Wade
Notes
Speakers: Richard Ransohof, Co-Founder and CMO Abata and Venture Partner, Third Rock Ventures, Thomas Wickham, CSO, GentiBio, Jonathan Zalevsky, Chief Research and Development Officer, Nektar Therapeutics and more.
 

Enquiries and Registration:

https://go.evvnt.com/991160-2?pid=4832
Mr. Treg Directed Therapies Summit Team
 
Categories
General Medicine
Languages
English
Congress fees
USD 2599.0 - USD 5846.0
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

OÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation AMREF - African Medical and Research FoundationnewTreeHelix - Forschung & Beratung WienCharité International AcademySwiss Tropical and Public Health InstituteCenter of ExcellenceEuropean Health Forum Gastein